215 studies found for:    "Eye Diseases, Hereditary" OR "Lenz microphthalmia syndrome"
Show Display Options
Download search resultsDownload the search results for:
"Eye Diseases, Hereditary" OR "Lenz microphthalmia syndrome" (215 records)
Download Content:
Zip file readers with free trial periods: WinZip or PKZip
Rank Status Study
1 Completed Fundus Changes in the Microphthalmy Eyes
Condition: Eye Diseases, Hereditary
Intervention:
2 Completed Efficacy of Subantimicrobial Dose Doxycycline for Moderate to Severe and Active Graves' Orbitopathy
Conditions: Graves Ophthalmopathy;   Graves Disease;   Eye Diseases;   Thyroid Diseases;   Endocrine System Diseases;   Eye Diseases, Hereditary;   Hyperthyroidism;   Autoimmune Diseases;   Immune System Diseases
Intervention: Drug: Doxycycline
3 Recruiting Doxycycline Treatment in Mild Graves' Orbitopathy
Conditions: Graves Ophthalmopathy;   Graves Disease;   Eye Diseases;   Thyroid Diseases;   Endocrine System Diseases;   Eye Diseases, Hereditary;   Hyperthyroidism;   Autoimmune Diseases;   Immune System Diseases
Interventions: Drug: Doxycycline;   Drug: placebo
4 Active, not recruiting Efficacy and Safety of Oral Valproic Acid for Retinitis Pigmentosa
Conditions: Retinitis Pigmentosa;   Retinal Diseases;   Eye Diseases;   Eye Disease, Hereditary;   Retinal Degeneration
Intervention: Drug: Valproic Acid
5 Completed Evaluation and Treatment of Patients With Inherited Eye Diseases
Condition: Hereditary Eye Disease
Intervention:
6 Completed Screening for Studies on Inherited Eye Diseases
Condition: Hereditary Eye Disease
Intervention:
7 Withdrawn Intravitreal Bevacizumab vs.Combination Therapy for CNV Due to Other Than AMD
Conditions: Choroidal Neovascularization;   Myopia;   Punctate Inner Choroidopathy (PIC);   Multifocal Choroiditis;   Ocular Histoplasmosis Syndrome;   Central Serous Chorioretinopathy (CSC);   Angioid Streaks;   Trauma, or Hereditary Eye Diseases
Interventions: Drug: Bevacizumab (Avastin; Genentech, Inc.);   Drug: Bevacizumab, Dexamethasone, Verteporfin Photodynamic Therapy
8 Recruiting Congenital Muscle Disease Study of Patient and Family Reported Medical Information
Conditions: Muscular Dystrophy;   Congenital Muscular Dystrophy;   Fukutin-related Protein Gene;   Limb Girdle;   FKRP Gene;   Childhood Onset LGMD;   Adult Onset LGMD;   POMT1;   POMT2;   POMGnT1;   LARGE;   Alpha Dystroglycan;   Dystroglycanopathy;   Centronuclear;   Multiminicore;   Multicore;   Minicore;   Congenital Fiber Type Disproportion;   Myotubular;   Nemaline;   Congenital Myopathy;   Neuromuscular;   Rigid Spine;   Phenotype-Genotype Correlation;   Cough Assisted Device;   Neuromuscular Disease;   Respiratory Exacerbation;   Invasive Ventilation;   Chest Physiotherapy;   Congenital Myopathies;   Genetic Mutations;   Hypertrophic Cardiomyopathy;   Wheelchair Use;   Cataract;   Opthalmoplegia;   Ullrich Congenital Muscular Dystrophy;   Intermediate Collagen VI Myopathy;   Laminin Alpha 2 Related Congenital Muscular Dystrophy;   MDC1A;   Merosin Deficient Congenital Muscular Dystrophy;   Congenital Muscular Dystrophy Undiagnosed;   Congenital Muscular Dystrophy Merosin Positive;   Walker Warburg Syndrome;   Muscle Eye Brain Disease;   Fukuyama;   Integrin Alpha 7 Deficiency;   Integrin Alpha 9 Deficiency;   Laminopathy;   Lamin AC;   SEPN 1 Related Myopathies;   Bethlem Myopathy;   Dystroglycanopathies;   LGMD2K;   LGMD2I;   LGMD2L;   LGMD2N;   Actin Aggregation Myopathy;   Cap Disease;   Central Core Disease;   Centronuclear Myopathy;   Core Rod Myopathy;   Hyaline Body Myopathy;   Multiminicore Myopathy;   Myotubular Myopathy;   Nemaline Myopathy;   Tubular Aggregate Myopathy;   Zebra Body Disease Myopathy;   Congenital Myopathy Other;   Reducing Body Myopathy;   Sarcotubular Myopathy;   Spheroid Body Myopathy
Intervention:
9 Recruiting Safety and Efficacy of Subretinal Implants for Partial Restoration of Vision in Blind Patients
Conditions: Retinitis Pigmentosa;   Retinal Degeneration
Intervention: Device: Device name: "Retina Implant model Alpha". Surgical implantation of medical device into eye
10 Completed Treatment of Congenital Stationary Night Blindness With an Alga Containing High Dose of Beta Carotene
Condition: Night Blindness
Intervention: Dietary Supplement: alga Dunaliella bardawil
11 Recruiting Stem Cell Models of Best Disease and Other Retinal Degenerative Diseases.
Conditions: Retinal Disease;   Bestrophinopathy;   Best Vitelliform Macular Dystrophy;   Adult Onset Vitelliform Macular Dystrophy;   Autosomal Dominant Vitreoretinalchoroidopathy
Intervention:
12 Active, not recruiting Feasibility Study of a Chronic Retinal Stimulator in Retinitis Pigmentosa
Condition: Retinitis Pigmentosa
Intervention: Device: Argus 16 Retinal Stimulation System
13 Active, not recruiting Adjuvant Treatment of Graves´ Ophthalmopathy With NSAID (aGO Study)
Condition: Graves´ Disease
Interventions: Drug: Diclofenac;   Drug: Methimazole;   Drug: L-thyroxin;   Drug: Propranolol;   Drug: Metoprolol
14 Completed Study of the Correlation Between Macular Thickness Analyzed by Optical Coherence Tomography and the Visual Functions in Retinitis Pigmemtosa
Condition: Retinitis Pigmentosa
Intervention:
15 Recruiting The Molecular Pathogenesis of Late-onset Fuchs' Endothelial Corneal Dystrophy
Condition: Fuchs' Endothelial Dystrophy
Intervention:
16 Completed Transcorneal Electrostimulation for Therapy of Retinitis Pigmentosa
Condition: Retinitis Pigmentosa
Intervention: Device: transcorneal electrostimulation
17 Active, not recruiting Argus® II Retinal Stimulation System Feasibility Protocol
Condition: Retinitis Pigmentosa
Intervention: Device: Argus II Retinal Stimulation System
18 Completed Transcorneal Electrical Stimulation Therapy for Retinal Disease
Conditions: Retinitis Pigmentosa;   Macula Off;   Primary Open Angle Glaucoma;   Hereditary Macular Degeneration;   Treated Retina Detachment;   Retinal Artery Occlusion;   Retinal Vein Occlusion;   Non-Arthritic-Anterior-Ischemic Optic-Neuropathy;   Hereditary Autosomal Dominant Optic Atrophy;   Dry Age Related Macular Degeneration;   Ischemic Macula Edema
Interventions: Device: Transcorneal Electrical Stimulation;   Device: DTL-electrode attached without energy
19 Active, not recruiting Transcorneal Electrical Stimulation - Multicenter Safety Study
Condition: Retinitis Pigmentosa
Intervention: Device: Electrostimulation
20 Terminated A Safety and Tolerability Study of Otelixizumab in Thyroid Eye Disease
Condition: Graves Ophthalmopathy
Interventions: Drug: Otelixizumab - low dose;   Drug: Otelixizumab - medium low dose;   Drug: Otelixizumab - medium high dose;   Drug: Otelixizumab - high dose;   Drug: Otelixizumab;   Drug: Methylprednisolone

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years